Find uplifting stories about heroes, innovations, and solutions
12 results for "neurodegenerative disease"
Spanish researchers discovered a cellular cleaning system that weakens in ALS patients, offering the first potential target to slow this devastating disease. The breakthrough came from studying donated tissue from patients who helped advance research even in their final years.
Four leading European research institutes have joined forces to speed up treatments for Alzheimer's, Parkinson's, and other brain diseases affecting millions. The CURE-ND Alliance brings together over 2,500 scientists working to transform how we understand and treat neurodegenerative diseases.
Three major Parkinson's organizations are asking Congress to boost NIH research funding to $600 million annually, representing hope for 1.2 million Americans living with the disease. The request comes as breakthrough treatments move closer to reality after decades of federal investment.
Tim Evans, diagnosed with ALS in 2014, chose to become the first volunteer in groundbreaking research at Johns Hopkins Medicine instead of letting his disease define his final chapter. His decision could help improve quality of life for thousands of ALS patients diagnosed each year.
A promising ALS treatment has enrolled its first patient in a major clinical trial that could slow disease progression. The drug showed encouraging results in early-stage patients during previous testing.
A groundbreaking ALS treatment has enrolled its first patient in a major clinical trial that could help slow disease progression in early-stage patients. The study follows encouraging results showing the drug helped preserve speech and breathing function in rapid-decline patients.
A student who spent summers in his grandfather's Kashmir clinic just became one of America's top young scientists. Ishaan Sharma is bridging the gap between lab research and real patients with neurodegenerative diseases.
A groundbreaking gene therapy called AMT-130 has slowed Huntington's disease progression by 75% in clinical trials, offering hope to families who've waited 154 years for effective treatment. The one-time treatment could preserve patients' ability to walk, speak, and connect with loved ones for years longer.
Scientists used artificial intelligence to create tiny antibody fragments that can function inside human cells, targeting proteins that cause Alzheimer's, Parkinson's, and other brain diseases. This breakthrough overcomes a major limitation in medicine development and could lead to new treatments for conditions affecting over one million people in the UK alone.
Canadian researchers discovered a groundbreaking way to stabilize damaged brain proteins using weak magnetic fields, opening new doors for treating diseases affecting over a million Canadians. The quantum biology breakthrough could revolutionize how we approach neurodegenerative disease treatment.
Scientists have found a way to use CAR T-cells, already proven to cure some cancers, to slow the devastating effects of ALS by targeting rogue immune cells in the brain. The breakthrough could extend lives and eventually help treat dementia and other neurodegenerative diseases.
Northwestern Medicine researchers discovered how to help mice with ALS live longer and stay stronger by targeting a protein that was accidentally protecting toxic buildup in their cells. The breakthrough opens a new path for treating multiple brain diseases.